Indication
End Stage Liver Disease
3 clinical trials
4 products
Clinical trial
Intraoperative Angiotensin 2 for the Prevention of Kidney Injury After Liver TransplantStatus: , Estimated PCD: 2024-09-01
Product
Angiotensin IIProduct
NorepinephrineClinical trial
Effect of Transfusion of Plasma During Orthotopic Liver Transplantation on Endothelial Glycocalyx Layer and Short-term Outcome in Patients With End-Stage Liver DiseaseStatus: Recruiting, Estimated PCD: 2024-12-31
Product
Fresh frozen plasmaClinical trial
A 12-Month, Open-Label Study Evaluating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Siplizumab as Induction Therapy in Patients With Autoimmune Liver Diseases Undergoing Liver Transplantation (SET-SAIL)Status: Not yet recruiting, Estimated PCD: 2025-12-31
Product
Siplizumab